Gintautas Bieliauskas
Latest contributions
Streamlining the TAVI pathway
21 May 2025 – From EuroPCR 2025
Optimize your TAVI pathway through this session focusing on streamlined pre-procedural planning, minimalist procedural techniques, and post-procedural discharge strategies. Learn how to safely deliver multiple cases per list and implement next-day or same-day discharge programs effectively.

New devices for structural interventions
21 May 2025 – From EuroPCR 2025
Discover emerging devices transforming structural heart interventions. This session highlights biomimetic valve designs, new transcatheter aortic valve systems, novel devices for aortic insufficiency, leaflet resection, left atrial appendage closure, and short self-expanding TAVR valves with promising early results.

TAVR implantation techniques: are they the same for all self-expanding TAV platforms?
25 Nov 2024 – From PCR London Valves 2024
Explore the differences between currently available self-expanding TAVI platforms and how they influence device selection and procedural techniques. A panel of experts discuss the pros and cons of these platforms and valuable tips and tricks to tackle various anatomical challenges effectively.

Lifetime management for the valve patient
20 Nov 2023 – From PCR London Valves 2023
This session focuses on acquiring the necessary knowledge for engaging in discussions with patients about the lifelong management of valve disease. It emphasizes understanding the relevance of life expectancy and comorbidities, as well as providing key information to support shared decision-making between healthcare professionals and patients.

TAVI outcomes outside the cathlab – Importance of haemodynamics and durability
23 May 2019 – From EuroPCR 2019
Watch this LIVE case to learn more on TAVI in failed surgical aortic bioprosthesis, how to minimise risk of patient-prosthesis mismatch and coronary protection.
A 91-year-old female with an active lifestyle underwent a surgical aortic valve replacement 15 years ago. She presents with NYHA III and CCS...
